BEST COLLABORATION IN THE PHARMACEUTICAL OR BIOTECHNOLOGY INDUSTRY
Biomunex signed a licensing agreement with Sanofi for the generation and development of bi-specific and multi-specific antibodies.
Eukarys collaborated with the University of Alberta to develop C3P3 technology and its applications in biologic manufacturing.
NHTherAguix collaborated with the Dana-Farber and Brigham and Women’s Hospitals on preclinical subjects first and are now moving on to a clinical trial on application of nanotechnologies to radiotherapeutic oncology in deep lung cancer and pancreatic cancer.
BEST COLLABORATION IN THE MEDTECH OR DIGITAL SECTOR
DTA Medical collaborated with Tufts University to develop a medical device allowing constant monitoring of wound healing critical factors.
Novadiscovery and BBN Cardio Therapeutics are collaborating to build an in silico model of atherosclerosis and establish a proof of concept of efficacy before in vivo clinical trials.
UroMems collaborated with the Mayo Clinic to develop a pivot study for a medical device to treat stress urinary incontinence.
BEST COLLABORATION DEDICATED TO THE DEVELOPING OR INDERSERVED POPULATIONS WOLDWIDE
Lysogene collaborated with Sarepta to develop a drug candidate in the treatment of MPSIIIA with gene therapy.
The Consortium constituted of the Praesens foundation, the French and Dakar Pasteur Institutes, Twist Bioscience and the University of Nebraska Medical Center developed an integrated solution for better preparedness and faster response to outbreaks and epidemics in high-risks areas.
Sparing Vision collaborated with the Foundation Fighting Blindness to develop and launch a breakthrough disease-modifier gene therapy treatment for Retinitis Pigmentosa.